Link between Constipation and Parkinson's Disease
Researhers have found from a long-term study that men who suffer from
constipation are nearly three times more likely to eventually develop Parkinson's disease. According to Robert Frank, Professor of Biostatistics and Statistics at the University of Texas School of Medicine, the connection between
constipation and Parkinson's was noted almost 2 centuries back from a clinical study.<...
Constipation can be a cause
Men who suffer from
constipation are more likely to get diagnosed with the progressive brain disease Parkinson's. Scientists have little idea why this should be the case, although some have suggested that the disease may have some effect on the function of the gut long before it manifests itself elsewhere. Dr Robert Abbott, who led the research, said: "It could help us more effectivel...
Take care of constipation
Researchers have stated that Men who suffer from
constipation are more likely to get diagnosed with the progressive brain disease Parkinson's some have suggested that the disease may have// some effect on the function of the gut long before it manifests itself elsewhere. Dr Robert Abbott, who led the research, said: "It could help us more effectively identify people with early or suspe...
Tegaserod offers relief for Chronic Constipation
Tegaserod, a new drug seems to the remedy of choice to treat chronic
constipation.//A new study published in the American Journal of Gastroentrology claims that, it is far more superior in effectiveness that other drugs used currently.Current laxatives used for treating chronic
constipation do not seem to offer the same degree of relief. Chronic
constipation is a common disorder, affecti...
Constipation Drug Linked to Heart Attack Pulled Out
Novartis AG, the Swiss pharmaceutical giant, has agreed to stop selling Zelnorm, a
constipation drug, following complaints that it is linked// to higher chances of heart attack and stroke. Officials of the Food and Drug Administration (FDA) of the US had advised the firm to pull the drug out of the market.(It is this Novartis that has challenged the rejection of its patent applicat...
More>>
Progenics and Wyeth Announce Positive Results from Three-Month
Clinical-Extension Study of Subcutaneous Methylnaltrexone for the
Treatment of Opioid-Induced Constipation in Patients with Advanced
Illness
TARRYTOWN, N.Y. & MADISON, N.J.--(BUSINESS WIRE)--Jun 28, 2007- Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) and WyethPharmaceuticals, a division of Wyeth (NYSE: WYE), today announcedpositive results from a three-month open-label extension study ofsubcutaneous methylnaltrexone for the treatment of opioid-induced
constipation (OIC) in patients with advanced illness. The resultsare sched...
New Study Demonstrates that Lubiprostone May Improve Symptom Relief
Rates in Adults with Irritable Bowel Syndrome with Constipation
(IBS-C)
WASHINGTON, May 21, 2007 /PRNewswire/ -- A new studydemonstrated that the active ingredient in Amitiza (lubiprostone),given 8 mcg twice a day, may improve symptom relief rates in adultswith irritable bowel syndrome with
constipation (IBS-C). Theseresults were presented as a late-breaker at Digestive Disease Week2007, the largest annual international meeting of digestive diseasespecialist...